250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Health Care VC Funds in China

A list of 50 VC funds that invest in Health care startups based in China. We rank investors based on the number of investments they made in Health care companies from China. We update this investor list every month.

Top 50 Health Care VC Funds in China

Investor Health Care China investments
Qiming Venture Partners 62
Sequoia Capital China 48
Med-Fine Capital 43
BioVenture 37
Lilly Asia Ventures 34
Highlight Capital 31
IDG Capital 31
Legend Capital 30
Frees Fund 29
Kaitai Capital 27
Legend Star 26
Puhua Capital 26
Northern Light Venture Capital 25
Marathon Venture Partners 23
BioTrack Capital 22
CD Capital 22
Cowin Capital 22
CDH Investments 21
Cowin Venture 20
Dalton Venture 19
Volcanics Venture 18
Sherpa Healthcare Partners 18
Hillhouse Investment 18
CASH Capital 18
Oriza Holdings 18
TF Capital 17
Huagai Capital 17
Sinopharm Capital 17
Plum Ventures 17
Sinovation Ventures 16
LYFE Capital 16
Gaorong Capital 16
Shenzhen Capital Group 16
Addor Capital 15
ZhenFund 15
Share Capital 14
Oriental Fortune Capital 14
SBCVC 13
Green Pine Capital Partners 13
Haibang Capital 13
Baidu Ventures 13
Cenova 13
Tiantu Capital 12
Fortune Venture Capital 12
Lotus Lake Ventures 12
Redhill Capital 12
Oriza Seed Capital (Oriza Yuandian) 12
Lenovo Capital and Incubator Group (LCIG) 12
Source Code Capital 12
Sunland Fund 12
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Qiming Venture Partners VC Fund · Shanghai, Shanghai, China · 45 investments in the past 12 months
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series B, Series A, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • INF Tech — INF Tech is an AI innovative company that specializes in large language models and develops trustworthy generative AI technologies.
  • DK MedTech — Dingke Medical is a medical device tech firm specializing in the R&D and production of vascular interventional medical treatment products.
  • Galaxy Bot — Galaxy Bot is an innovative robotics company that provides intelligent universal service robotic products.
Sequoia Capital China VC Fund · Beijing, Beijing, China · 33 investments in the past 12 months
We help founders build enduring companies.
Show more
Investment focus
  • Biotechnology, Health Care, Artificial Intelligence
  • Series A, Series B, Series C
  • China, United States, Australia
Portfolio highlights
  • Xingkeyuan — Star Science is a high-performance lithium battery silicon-carbon negative electrode material research and development company. It has achieved small-scale mass manufacture of nano-silicon as well as the experimental development of high-efficiency silicon-carbon composite materials.
  • Huaxuan Sensing — Huaxuan Sensing is a sensor technology company that focuses on the development of resolver sensors for the new energy automobile industry.
  • Martial Arts Awakening — Martial Arts Awakening is a blockchain game developer focused on the long-term development of blockchain, Web3.0, Metaverse, and NFT ecosystems.
Med-Fine Capital VC Fund · Shanghai, Shanghai, China · 3 investments in the past 12 months
Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Seed, Series B
  • China, United States
Portfolio highlights
  • Rebbeca Med — Rebecca is committed to the application of precision-controlled MEMS radio frequency technology in clinical disease control and rehabilitation. Its core technology comes from the core team's many years of experience and achievements in research and development and productization at the University of California, Fortune 500 medical equipment,and electronic equipment companies. The company cooperated with domestic university research institutes and many top three hospitals in Beijing, Shanghai, and Hangzhou to independently develop micro-radio frequency technology that surpassed similar products in Europe and America. It focuses on delivering innovative medical solutions to the hands of professional caregivers. Rebecca's team possesses technical expertise in micro-devices, RF, and device integration through years of field practice in micro-electronics and clinical innovation.
  • Zhuanma Biotech — Zhuanma Biotechnology is a gene editing service provider dedicated to clinically developing effective ultra-small gene editors into genetic therapeutics that are "curable once and for all."
  • Phrontline Biopharma — Phrontline Biopharma specializes in the development of ADC to address unmet medical needs in the field of oncology.
BioVenture VC Fund · Suzhou, Jiangsu, China · 6 investments in the past 12 months
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Seed
  • China, United States, Taiwan
Portfolio highlights
  • Secretech — Secretech is a R&D-driven biotechnology company.Secretechis creates biomarkers and cellular exosomes and is dedicated to the discovery and development of novel biomarkers and cellular exosomes.
  • Gachun Biotech — Gachun Biotech is a pharmaceutical intermediates industrialization platform that focuses on APIs, or pharmaceutical intermediates.
  • Changsha Morning Shine — Changsha Morning Shine is an innovative pharmaceutical company that specializes in R&D outsourcing, biomedicine, chemical drugs, and biotechnology services.
Lilly Asia Ventures VC Fund · Shanghai, Shanghai, China · 14 investments in the past 12 months
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • ProfoundBio — ProfoundBio is an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer.
  • Targeting One — Targeting One is an in-vitro diagnostic product developer.
  • Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
Highlight Capital VC Fund · Nanjin, Jiangsu, China · 5 investments in the past 12 months
They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Seed
  • China, United States, Portugal
Portfolio highlights
  • EdgeRock — EdgeRock offers an automotive integrated brake-by-wire system. EdgeRock supplies highly integrated capabilities for big and heavy load technologies.
  • Hydropeng Technology — Hydropeng Technology is a company that developes solid oxide fuel cell specializes in the engineering development of solid oxide fuel cells (SOFC) and electrolytic cells (SOEC). Hydropeng Technology applies its extensive R&D capabilities in materials, chemistry, mechanics, and other fields to create efficient hydrogen energy systems thatfulfill the green energy demands of global ESG development.
  • Shifan Microelectronics — Shifan Microelectronics offers intelligent display SOC chip design and development services. Shifan Microelectronics is primarily concerned with the research and development of display processing and device technologies.
IDG Capital VC Fund · Beijing, Beijing, China · 19 investments in the past 12 months
IDG Capital is an investment firm that funds early- to growth-stage companies in the technology sector. Today they work with private equity and venture capital fund managers, investment advisors, and business entities from around the world. Their limited partners include many internationally reputable investors, including sovereign wealth funds,pension funds, institutional investors, major charities, university endowments, family offices, and business luminaries.IDG Capital brings a powerful combination of global perspective and local experience to investment management. As long-term value investors, they are highly skilled at mobilizing global resources to address local needs, especially for Inbound and outbound opportunities in China and the rest of Asia. Their highly skilled team has an in-depth understanding of the Chinese market and enjoys close relationships with many influential business leaders.
Show more
Investment focus
  • Software, Internet, E-Commerce
  • Series A, Series B, Series C
  • China, United States, India
Portfolio highlights
  • Galaxy Bot — Galaxy Bot is an innovative robotics company that provides intelligent universal service robotic products.
  • Sentient — Community-built open AGI
  • Chengdu Pukang Biotechnology Co. — Chengdu Pukang Biotechnology Co., Ltd specializes in the development, production, and supply of high-purity single molecular PEG series derivatives, polypeptide long-acting drug side chains, and their intermediates. The company focuses on serving the pharmaceutical industry with a range of chemical supplies that are crucial for drug development andmanufacturing processes. With a professional R&D team, Chengdu Pukang Biotechnology is dedicated to advancing pharmaceutical intermediates technology and providing solutions that meet the evolving needs of the healthcare sector. The company's commitment to research and development is evident in its continuous efforts to innovate and improve its product offerings to support the pharmaceutical industry.
Legend Capital VC Fund · Beijing, Beijing, China · 25 investments in the past 12 months
Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series B, Series A, Series C
  • China, United States, South Korea
Portfolio highlights
  • MS Energy — MS Energy is a technology-driven enterprise that specializes in providing green energy solutions.
  • DK MedTech — Dingke Medical is a medical device tech firm specializing in the R&D and production of vascular interventional medical treatment products.
  • Zhongke Guosheng — Zhongke Guosheng is a bio-based materials R&D firm that designs and develops furan-based bio-based materials.
Frees Fund VC Fund · Beijing, Beijing, China · 15 investments in the past 12 months
By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.
Show more
Investment focus
  • Artificial Intelligence, Biotechnology, Medical
  • Series A, Seed, Angel
  • China, United States, Singapore
Portfolio highlights
  • Vibronix — Vibronix innovates for Precision Healthcare with spectroscopic imaging, optical & acoustic sensing, and machine learning.
  • Xinyong Technology — Xinyong Technology provides services for the diagnosis and treatment of cardiovascular diseases. It is committed to providing easy access to correct blood pressure information at any time and from any location, thereby avoiding or decreasing the harm caused by cardiovascular and cerebrovascular disorders.
  • Hangkai Microelectronics — Hangkai MicroTech focuses on the research, development, and manufacturing of Mems technology and products, with an emphasis on the demand for domestic sensor substitutes.
Kaitai Capital VC Fund · Hangzhou, Zhejiang, China · 4 investments in the past 12 months
KAITAI CAPITAL, founded in 2009, is a professional investment management organization that mainly engaged in innovative investment, industrial investment, and wealth management business. Fields of investment include biopharma, healthcare services, agriculture tech, consumer business, digital technology and etc.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Series A, Angel, Seed
  • China, United States
Portfolio highlights
  • Huaboron Neutron — Huaboron Neutron is a biotechnology company that develops boron drugs and boron neutron capture therapy devices for the diagnosis of malignant cancers.
  • Nafi Pharmaceuticals — Nafi Pharmaceuticals develops novel medications for central nervous system illnesses.
  • Atom Bioscience & Pharmaceutical — Atom Bioscience is a clinical-stage biotechnology company developing new treatments for inflammatory and metabolic diseases such as chronic gout and non-alcoholic steatohepatitis.
Legend Star VC Fund · Beijing, Beijing, China · 3 investments in the past 12 months
Legend Star helps entrepreneurs create great businesses through investments, CEO training sessions and an entrepreneurs alliance.Since 2008, Legend Star has incubated and invested in nearly 600 companies and is deeply integrated in the Chinese entrepreneurial ecosystem.Legend Star is the independent early-stage investment arm of LegendHoldings. Legend Holdings is the parent company of Lenovo, Raycom Real Estate, Joyvio Agribusiness and a large range of fast-growing Chinese companies.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Angel, Seed
  • China, United States, France
Portfolio highlights
  • Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
  • Arnatar Therapeutics — Arnatar Therapeutics is a biopharmaceutical company that specializes in the development of novel nucleic acid medications.
  • Carbon Energy Technology — Carbon Energy Technology develops technology for carbon utilization and its commercialization.
Puhua Capital VC Fund · Hangzhou, Zhejiang, China · 3 investments in the past 12 months
Puhua Capital is an equity investment firm that focuses on early and middle project. Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Angel
  • China, United Kingdom, United States
Portfolio highlights
  • Zozen — Zhuzheng Robotics is a medical robot manufacturer and developer specializing in minimally invasive spinal surgery. It specializes in researching new, intelligent, high-end medical devices with independent intellectual property rights, researching and developing products related to minimally invasive spinal surgery, and providing related services.
  • Cascade — Cascade produces novel medications that target nuclear receptors for treating metabolic disorders and inflammation.
  • Zhejiang Tianneng New Material — Zhejiang Tianneng New Material manufactures batteries as well as recycles, removes, and re-uses old lithium batteries.
Northern Light Venture Capital VC Fund · Beijing, Beijing, China · 13 investments in the past 12 months
Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Series A, Series B, Seed
  • China, United States, South Korea
Portfolio highlights
  • RootData — Providing the most up-to-date and complete Crypto project financing information,detailed project background,team members,investors,news updates,token price data,and on-chain assets tracking. Dedicated to making Crypto investing easier.
  • Wanglitong — Wanglitong manufactures lithium battery auxiliary materials. It currently specializes on lithium battery films and membrane materials. Its current product lines include brown high-temperature tape, milky white OPP tape, and TPU expansion tape, all of which have reached mass production.
  • Coordinate System Intelligence — Coordinate System Intelligence is a provider of automotive brake-by-wire system solutions. It focuses on providing core technology solutions.
Marathon Venture Partners VC Fund · Shanghai, Shanghai, China
Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Angel
  • China, Hong Kong, United States
Portfolio highlights
  • Bingjing Smart — Bingjing Smart is a cardiovascular interventional imaging company. It is an acoustics-based startup that uses imaging as a form of communication and is aiming for the digital medical revolution. It creates specialist digital interventional imaging products for heart and vascular illnesses. It helps in advancement of digital cardiovascularinterventional imaging, leveraging digital to empower the entire process of cardiovascular disease diagnosis and treatment.
  • Minglan Shijia — Minglan Shijia focuses on the health of women's whole reproductive cycle and deeply cultivates the field of digital therapy in obstetrics and gynecology.
  • Neowise — XinjingZhiyuan is an immune cell therapy company focusing on solid tumors.
BioTrack Capital VC Fund · Shanghai, Shanghai, China
BioTrack Capital is a China-based investment firm.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Seed
  • China, United States, Singapore
Portfolio highlights
  • Acchrom Tech — Huapu Instrument (Beijing) Technology Co., Ltd. is committed to building Huapu into a well-known national brand in the field of chromatography, and is an enterprise that provides the overall solution of "product + technical service" in the field of chromatography. The company formulates differentiated marketing strategies, builds anationwide marketing team centered on key provinces, and builds a professional and efficient marketing network.
  • Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
  • Yuce Biotechnology — Yuce Biotechnology is a high-tech company focused on the industrialization of single-molecule immunodiagnostic technologies.
CD Capital VC Fund · Shanghai, Shanghai, China · 4 investments in the past 12 months
CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Series B, Seed
  • China, United States
Portfolio highlights
  • Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
  • Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
  • Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.
Cowin Capital VC Fund · Shenzhen, Guangdong, China · 25 investments in the past 12 months
Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.Cowin Capital was founded in 2000 and is headquartered in Shenzhen, China.
Show more
Investment focus
  • Manufacturing, Health Care, Software
  • Series A, Series B, Angel
  • China, Hong Kong, United States
Portfolio highlights
  • Bytetree — Bytetree is a technology company that focuses on providing the one-stop AI data services for data collection, cleaning, labeling, management, and storage for OEMs and autonomous driving solution providers, covering bicycle intelligence. , vehicle-road coordination, and smart cockpit three scenarios.
  • IKX technologies — IKX technologies specializes in designing and manufacturing INS/IML/IMR diaphragms for automotive interior and exterior decoration. With a technical route, the company ensures product performance is comparable to overseas suppliers while significantly reducing production costs. Yongmaxi's business with major OEMs is progressingsmoothly, with stable batch shipments and cooperation with first-tier OEMs on popular models.
  • Sino Soar Hybrid — SINOSOAR provides global customers with solar mini-grid, solar off-grid system solutions and energy management system solutions, international solar power generation projects, solar mini-grid product integration.
CDH Investments VC Fund · Kowloon City, Kowloon, Hong Kong · 25 investments in the past 12 months
CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.
Show more
Investment focus
  • Manufacturing, Health Care, Biotechnology
  • Series A, Series B, Series C
  • China, United States, Canada
Portfolio highlights
  • Ruijiakang — Ruijiakang focuses on the research, development, and application of green synthetic biology production, as well as the layout and research of biofuels and biomaterials for non-grain anaerobic organic alkyd pipelines, and employs Zymomonas mobilis.
  • Bach Hoa Xanh — Bach Hoa Xanh is a chain of minimarts and food stores that concentrate in fresh produce and everyday household necessities.
  • CuPure Biotechnology — CuiPure Biotechnology is a developer of purification processes and materials for cell gene therapy, overcoming technical difficulties in molds, fluid mechanics, material synthesis, and bioengineering. They aim to improve resolution, binding capacity, processing speed, and filler costs for large-scale industrial purification.
Cowin Venture VC Fund · Beijing, Beijing, China · 9 investments in the past 12 months
Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies graduated from their angel investment portfolio. Cowin’s business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Angel, Series B
  • China, United States, Canada
Portfolio highlights
  • Xingmu — Xingmu creates cutting-edge gene editing technologies and gene therapy solutions for ocular illnesses.
  • ZWI Therapeutics, Inc. — ZWI Therapeutics biotech therapeutics polymer
  • Xindi Digital Engineering System — Xindi Digital Engineering System specializes in the development of 3D CAD software for manufacturing enterprises.
Dalton Venture VC Fund · Shanghai, Shanghai, China · 7 investments in the past 12 months
Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Series A, Series B, Angel
  • China
Portfolio highlights
  • MacroLux — MacroLux operates as a medical technology company focusing on endoscopic interventional business. MacroLux develops endoscopic interventional therapy solutions and promote them to the majority of medical customers.
  • Kangyuan Medical — Kangyuan Medical is committed to developing, and manufacturing a new generation of precise and effective blood purification adsorption materials.
  • Jichen Biotechnology — Jichen Biotechnology designs, manufactures, supplies, and maintains automation and information equipment systems.
Volcanics Venture VC Fund · Changning, Shanghai, China
Volcanics Venture was founded in May 2016. They identify, invest in, and serve the most promising companies and outstanding entrepreneurs in Internet Innovation, Intelligent Technology and Healthcare industry. Managing Partners Suyang Zhang, Yeshun Dong and Ying Wu have been working closely for years as first-class USD/RMB fund managers.They have more than 60 years of aggregated VC investment and corporate management experience, as well as in-depth understanding of three focused fields. Volcanics Venture brings a powerful combination of global perspective and local experience to investment management, striving to provide sustainable value-added service to their portfolio companies and bring superior return to their limited partners.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Series A, Series B, Seed
  • China, United States
Portfolio highlights
  • Fabrie — Fabrie develops collaboration tool for designers that has functions such as multi-person collaboration, table and diagram association, cloud storage and sharing.
  • Aiagain — Aiagain is the provider of an online WeChat management platform for WeChat sellers.
  • Fengtai Technology — Focusing on industrial information security, Fujian and Taiwan technology mainly provides professional, standard chemical control safety consulting and evaluation services to ensure information security of key industrial information infrastructure and improve security protection solutions. It mainly serves the government, industry customers, designinstitutes, research institutes, institutes, integrators and hardware and software manufacturers. Through visual, process and customized tools and methods, it helps users to carry out effective risk management and reliable operational support. .
Sherpa Healthcare Partners VC Fund · Beijing, Beijing, China · 3 investments in the past 12 months
Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • China, United States, Kenya
Portfolio highlights
  • Alamar Biosciences — Next-gen proteomic platform with ultra-high sensitivity and multiplexing capability for plasma protein detection and liquid biopsies.
  • New Vision Medical — New Vision Medical is an IT infrastructure service provider that offers clinical trial-related digital platforms and services.
  • Leadsynbio — Pilot Bio is a bio-manufacturing technology research and development company, focusing on bio-manufacturing of major chemical products, bio-process substitution in heavy-polluting industries, etc., providing users with bio-catalytic synthesis processes, enzyme product research and development, production, sales, and downstream companies with enzymeengineering , Technical service outsourcing and production service outsourcing of strain transformation and metabolic engineering.
Hillhouse Investment VC Fund · Changyang, Beijing, China · 5 investments in the past 12 months
Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Series B, Series A, Series C
  • China, United States, India
Portfolio highlights
  • Muyanzhiyu — Muyanzhiyu is a software development service provider that specializes in the creation of intelligent vehicle equipment, software development, and the production of basic artificial intelligence software.
  • Silicon Box — We are an advanced chiplet interconnection company specialising in cutting-edge semiconductor integration services. Learn more about our proprietary integration technology.
  • Global Data Solutions — Global Data Solutions designs, builds, and operates data centers in the People's Republic of China together with its subsidiaries. It provides colocation, managed hosting, and managed cloud services, as well as consulting services. Global Data Solutions's data centers service customers that primarily operate in the Internet and bankingindustries in Shanghai and Beijing municipalities; and Jiangsu, Guangdong, Sichuan, and Hebei Provinces. It serves cloud service providers, Internet companies, financial institutions, telecommunications and IT service providers, and large domestic private sector and multinational corporations. William Wei Huang founded Global Data Solutions in 2000. It has its headquarters in Shanghai in the People's Republic of China.
CASH Capital VC Fund · Beijing, Beijing, China · 2 investments in the past 12 months
CASH invests in emerging industries such as information technology and healthcare and focuses on fast-growing businesses in the start-up and growth stage.
Show more
Investment focus
  • Health Care, Biotechnology, Manufacturing
  • Series A, Series B, Series C
  • China, United States
Portfolio highlights
  • Gene Cradle — Gene Cradle is a genetic company that develops gene therapy drugs to treat rare genetic diseases as well as chronic diseases.
  • Century Yunan — Century Yunan is a new energy vehicle charging solution provider.
  • Beijing KYKY Technology — KYKY is a supplier of vacuum acquisition and testing products for the Chinese market. Its products are relevant for electro-optics, ion optics, vacuum physics, and other technical engineering projects.
Oriza Holdings VC Fund · Suzhou, Jiangsu, China · 18 investments in the past 12 months
Oriza Holdings is a Chinese management fund that covers equity, debt financing, and investment since 2007.
Show more
Investment focus
  • Health Care, Manufacturing, Biotechnology
  • Series A, Series B, Series C
  • China, United States, Canada
Portfolio highlights
  • Zhongke Jiahe — Zhongke Jiahe develops compilation technology and aspires to build a universal, low-cost, high-performance fundamental software tool chain.
  • CATUG Biotechnology — CATUG is focused on the development and application of new biomedical technologies. It provides one-stop CDMO services for the entire industry chain from quality research and clinical application to industrialization. It has R&D centers and industrialization bases in Suzhou and Wuhan.
  • Tetrahedron New Energy — Tetrahedron New Energy is an energy technology company that specializes in the development of lithium-ion battery core material solutions.
TF Capital VC Fund · Pudong, Shandong, China
TF Capital is a proprietary trading company that specializes in foreign exchange and invests in early stage ventures.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Series A, Series B, Seed
  • China, United States
Portfolio highlights
  • AskGene Pharma — AskGene Pharma is developing novel cytokine prodrugs to address critical unmet medical needs in oncology and autoimmune disease. Learn about our SmartKine platform.
  • Neowise — XinjingZhiyuan is an immune cell therapy company focusing on solid tumors.
  • Avenzo Therapeutics — Developing the next generation of oncology therapies for patients.
Huagai Capital VC Fund · Beijing, Beijing, China · 4 investments in the past 12 months
Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Angel
  • China, United States, Hong Kong
Portfolio highlights
  • Bluesail Surgical — Bluesail Surgical is a surgical device company that specializes in the development of innovative surgical instruments for cardiovascular and cerebrovascular treatments.
  • Ai Sensing Technology — Ai Sensing Technology is a national high-tech enterprise that focus on the research, development and production of bionic olfactory chips.
  • Bowang Pharmaceutical — Bowang Pharmaceutical is an RNAi drug research and development platform focused on siRNA drug development.
Sinopharm Capital VC Fund · Shanghai, Shanghai, China
Sinopharm Capital is a private equity arm of China National Pharmaceutical Group Corporation that specializes in medical and healthcare, pharmaceuticals, biotechnology, medical devices, healthcare and medical supply, and services for elderly and persons with disability. It seeks to invest in China. Sinopharm Capital was founded in June 2012 and isbased in Shanghai, China.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Seed
  • China, United States, Canada
Portfolio highlights
  • Xishan — Xishan is a surgical equipment and consumables manufacturing company.
  • Metanovas — Metanovas is a metabolic drug developer focused on combining artificial intelligence with life sciences, using deep learning.
  • Artivila Therapeutics — Artivila Therapeutics is a pharmaceutical company focused on improving patient's lives through an AI-powered drug discovery engine. The company is committed to discover the best therapeutical solutions to neuro-degenerative diseases, cancers, and autoimmune diseases empowered with an integrated AI-driven innovative drug discovery platform,providing first-in-class new molecules consistently and efficiently.Artivila Therapeutics was founded in 2018 and is based in ShenZhen, China.
Plum Ventures VC Fund · Changzhou, Zhejiang, China · 3 investments in the past 12 months
Plum Ventures is a venture capital company that aims to encourage young people to become entrepreneurs. It specializes ins providing seed and early-stage investments in the technology, new media, and telecommunications industry. The firm was founded in May 2014 and is based in Changzhou, China.
Show more
Investment focus
  • Software, E-Commerce, Internet
  • Series A, Angel, Seed
  • China, United States, Japan
Portfolio highlights
  • Huimaiche — Huimaiche is a company that provides full-chain solutions for new retail in the automotive industry. It is an Internet-based high-tech company that combines online system development, brand management, full-brand automobile sales, aftermarket integration, and new retail in life.
  • HooRii Technology — HooRii Technology is a provider of commercial distribution software systems spawned by the structural Internet of Things concept. It specializes ini end-to-end, edge-to-edge, software, hardware, and other Thread solutions.
  • Yunyao Aerospace Technology — Yunyao Aerospace Technology is a comprehensive service platform that integrates "Global Space Weather Data Production"+"Space Weather Data. The company is based in Tianjin, China.
Sinovation Ventures VC Fund · Beijing, Beijing, China · 14 investments in the past 12 months
Sinovation Ventures is a full-service venture capital firm that actively invests in the Chinese technology market.
Show more
Investment focus
  • Software, Artificial Intelligence, Internet
  • Series A, Seed, Series B
  • China, United States, Singapore
Portfolio highlights
  • Hope Medicine — Hope Medicine is committed to researching, developing and commercializing the first innovative drugs aimed at improving the quality of life for a wide range of popular male and female diseases.
  • Magair Chemical — Magair Chemical is a chemical synthesis CRO that was founded by Magera Technology. It is committed to using automated and intelligent platforms to provide new drug R&D customers with a new generation of chemical synthesis CRO services, significantly shortening the delivery of chemical synthesis links in the new drug R&D cycle, andsignificantly reducing the costs associated with chemical synthesis, removing pharmaceutical synthesis's current reliance on manual operations.
  • Heranova Lifesciences — Hekaiwei is a provider of innovative solutions for women's health.
LYFE Capital VC Fund · Shanghai, Shanghai, China · 4 investments in the past 12 months
In our inaugural fund, we are only seeking biotechnology, pharmaceutical, medical device, diagnostic, healthcare service and digital health companies with an established product foundation but need a bit more capital to accelerate its growth in Greater China. During this critical time, we work closely with our portfolio companies and support theirneeds not only by providing capital but with market planning, talent acquisition, global expansion and global partnership support.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Series C
  • China, United States, France
Portfolio highlights
  • ProfoundBio — ProfoundBio is an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer.
  • Magair Chemical — Magair Chemical is a chemical synthesis CRO that was founded by Magera Technology. It is committed to using automated and intelligent platforms to provide new drug R&D customers with a new generation of chemical synthesis CRO services, significantly shortening the delivery of chemical synthesis links in the new drug R&D cycle, andsignificantly reducing the costs associated with chemical synthesis, removing pharmaceutical synthesis's current reliance on manual operations.
  • Elite Technology — Elite Technology is a company that specializes in the development of chromatographic techniques, workstations, and high-performance liquid chromatography equipment for analysis, preparation, and industrial production.
Gaorong Capital VC Fund · Wangjing, Beijing, China · 6 investments in the past 12 months
Investors of Gaorong Capital include world-class sovereign wealth funds, university endowment funds, family foundations, pension funds and fund of funds, as well as successful entrepreneurs, including founders and managements of Tencent, Alibaba, Baidu, JD, Xiaomi, Focus Media and VIPShop. They will provide with valuable industry resources,entrepreneurial experience, and global perspectives.
Show more
Investment focus
  • Information Technology, E-Commerce, Software
  • Series A, Series B, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • BMSer Technoogy — Hangzhou Xieneng Technology Co., Ltd. (stock code: 836506) , having the core technology of independent intellectual property rights ,is a high-tech enterprise that specialized in new energy battery management technology research and development, production and management. The company was founded in May 2012, and the registered capital is13 million 500 thousand yuan RMB. It is located in Xihu District Zhejiang science and technology industry building in Hangzhou, Zhejiang Province, and is subordinate to the national high and new development zone. It has been founded by several overseas returnees, and has been invested by well-known investment institutions in China. The company adheres to the management concept of "first-class technology, quality first, green energy and benefit human", and is committed to providing battery management and maintenance solutions for customers. Relying on independent intellectual property rights and innovation mechanism, it has applied for invention patents 19, utility model patents 22 and software copyright 24. The company is based on self developed power integration chip and consistency. The battery active balance management system has the characteristics of reasonable design, novel structure, excellent performance and convenient installation and maintenance, and has reached the leading and international advanced level in China. By adhering to the spirit of "innovation, concentration, openness and tolerance", coeng technology has condensed a number of excellent R & D personnel and market management elite, and established an overseas R & D institution in the Silicon Valley of the United States. With innovative technology and advanced project management experience, the company provides customers with first class and most valuable products and services. At present, the company has more than 10 models of three series battery management systems, such as electric vehicles, scenery and storage, backup power supply, and many large professional battery manufacturers and electric vehicle manufacturers in China. Home, micro grid photovoltaic enterprises and national appliance network companies and other enterprises have formed extensive market cooperation relationship.
  • Linton Automobile — Linton Automobile is a manufacturer of automotive accessories and parts.c
  • Arnatar Therapeutics — Arnatar Therapeutics is a biopharmaceutical company that specializes in the development of novel nucleic acid medications.
Shenzhen Capital Group VC Fund · Shenzhen, Guangdong, China · 12 investments in the past 12 months
Shenzhen Capital Group Co., Ltd (“SCGC”) is a limited venture capital company established by Shenzhen Government in 1999. Since its establishment, SCGC has focused on cultivating national industries, shaping national brands, promoting economic transformation and emerging industriesdeveloping. SCGC has registered capital of 5.42 billion RMB, andtotal AUM of 338.99 billion RMB. SCGC primarily invests in SMEs, innovative high-tech enterprises, enterprises in emerging industries, and enterprises in start-up period, growth period and in transformation, covering industries supported by national policies, including IT, internet, new media, biopharma, new energy, environmental protection, chemical engineering, new material, high-end equipment manufacturing, consumption goods, modern service, etc. By the end of April 2019, SCGC ranked the first based of the number of portfolio companies and the number of listed portfolio companies: 994 portfolio companies, investments totaling 43.9 billion RMB, 145 of which have been listed in 16 capital markets worldwide.
Show more
Investment focus
  • Manufacturing, Health Care, Software
  • Series A, Series B, Series C
  • China, United States, Japan
Portfolio highlights
  • Won sec — Won sec is a network and information security provider focusing on formal verification and security certification. They offer security solutions for major industries like aviation, aerospace, and blockchain. Wangan Technology has obtained patents and software copyrights, and their core technologies have been applied to manned space projects and keynational enterprises.
  • QH Quartz — QH Quartz manufactures domestic professional quartz device processors and related material devices for the semiconductor, photovoltaic, and optical fiber industries.
  • Hannuo Medical — Hannuo Medical is a medical technology company that specializes in the development of high-end medical devices for critical extracorporeal life support.
Addor Capital VC Fund · Nanjing, Jiangsu, China · 36 investments in the past 12 months
Addor Capital offers investment services by financing early stage ventures and holding securities of other companies.
Show more
Investment focus
  • Manufacturing, Electronics, Semiconductor
  • Series A, Series B, Funding Round
  • China, Hong Kong, United States
Portfolio highlights
  • Jitu Express — Jitu Express is a logistics service operator, it provides customer-oriented, efficiency-based logistics solutions through intelligent infrastructure and digital networks.
  • Lanxiang Environment — Lanxiang Environment is a high-tech company that specializes in environmental governance system engineering, as well as the manufacture of energy-saving and water-saving intelligent equipment. It has evolved from a single composite material manufacturing sector to a multifaceted operation that includes cooling and heat exchange equipment,environmental protection governance engineering, energy- and water-saving engineering, novel material intelligence, and other enterprises.
  • Arthur Pharmaceuticals — Arthur Pharmaceuticals is a high-tech innovative pharmaceutical manufacturer.
ZhenFund VC Fund · Beijing, Beijing, China · 11 investments in the past 12 months
ZhenFund is a seed fund founded by former entrepreneurs to invest in the most promising innovators. New Oriental co-founders Bob Xiaoping Xu and Victor Qiang Wang established ZhenFund in 2011 in collaboration with Sequoia Capital China. ZhenFund now has a network of over 800 portfolio companies, including over 30 unicorns based in China. Webelieve that great businesses start with exceptional founding teams. We are dedicated to helping our entrepreneurs build successful companies by providing them with mentorship and the best resources available. Some of our services include biannual demo days to top Chinese VCs, ZhenHR services, marketing and PR consulting, as well as fundraising. Our strong and large CEO network also facilitates entrepreneurs helping each other, especially via our WeChat platform. ZhenFund has been ranked as the “#1 Early-Stage Investment Firm” for six years. Bob Xiaoping Xu, Founder of ZhenFund, has been named on the Midas List since 2016 and ranked #11 in 2019. Anna Fang, Founding Partner and CEO of ZhenFund, has been named on the Midas List since 2019 and made her 4th appearance as #12, and #1 on Midas Seed List in 2022.
Show more
Investment focus
  • Artificial Intelligence, Software, E-Commerce
  • Series A, Seed, Series B
  • China, United States, Singapore
Portfolio highlights
  • UXLINK — UXLINK is a social infrastructure comprised of social protocols and a collection of Dapps.UXLINk creates groundbreaking landing sceneries for web3 groups.
  • MioTech — MioTech is an artificial intelligence platform that empowers investment managers to better serve their clients in a world of complex data. By integrating and analyzing data from all types of sources, MioTech streamlines the entire investment process, creating an ultimate data-driven investing experience. MioTech has offices in Shanghai and HongKong.MioTech is backed by Horizons Ventures, ZhenFund, and prestigious individual investors around the world.
  • Yi'an Holdings — Yi'an Holdings is a financial services company that provides one-stop investment banking services to small and medium-sized companies.
Share Capital VC Fund · Shenzhen, Guangdong, China
Share Capital is a venture capital firm specializing in seed, start-up, early, middle, growth capital, and Pre-IPO investments. it primarily invests in big living, medical healthcare, and internet innovation. In medical healthcare, it seeks to invests in pharmaceuticals, innovative equipment, biotechnology, diagnostic testing equipment andreagents, anti-infectives, drug discovery, medical health service, mobile medical services, and informatization.
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Series A, Series B, Angel
  • China, United States, Colombia
Portfolio highlights
  • Depp CNC — Depp CNC is a research and development manufacturer of CNC machine tools and core accessories.
  • Microview — Microview is a high-tech enterprise specializing in the research and development of high-precision complex process chip packaging equipment.
  • Jodell Robotics — Jodell develops intelligent robotic equipment designed to serve in automotive and logistics industries.
Oriental Fortune Capital VC Fund · Shenzhen, Guangdong, China · 5 investments in the past 12 months
Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.
Show more
Investment focus
  • Software, Manufacturing, Information Technology
  • Series A, Series B, Seed
  • China, United States
Portfolio highlights
  • Renshuo Solar — Renshuo Solar is a manufacturer of perovskite tandem solar panels.
  • Leen Automation — Leen Automation is an automation technology company that focuses on the development and manufacturing of servo drives and motors.
  • Yihua New Energy — Yihua New Energy manufactures bipolar sodium-ion batteries designed based on low-cost solid electrolyte materials.
SBCVC VC Fund · Shanghai, Shanghai, China
Established in 2000, SB China Capital (SBCVC) is a leading venture capital and private equity firm that manages both USD and RMB funds. Their investment focuses on high-tech, high growth companies in TMT, clean technology, healthcare, consumer/retail, and advanced manufacturing sectors; and they invest across all stages of companies.Withextensive entrepreneurial and operating experiences, their professional and seasoned deal team members recognize the vision and champion the ideas of start-up companies. In addition to providing capital support, they help their portfolio companies realize their strategic and commercial potential by giving value-adding services and advices including planning, business development, recruiting and resources deployment.They have a proven track record and solid reputation in identifying high potential start-ups and creating successful industry-leading companies. Some of their spotlight portfolio companies are Alibaba, Taobao, Focus Media, GDS, BGI, Ankon, Di’an, and Edan.With their operational headquarters located in Shanghai and regional offices spread in Beijing, Shenzhen, Chengdu, Hangzhou and Taiwan, they have an extensive coverage of the greater China region and access to potential investment opportunities.
Show more
Investment focus
  • Health Care, Software, Information Technology
  • Series A, Series B, Series C
  • China, United States, Australia
Portfolio highlights
  • HaploX Biotechnology — HaploX Biotechnology is a Shenzhen-based genetic sequencing company.
  • Shengyin Optoelectronics — Shengyin Optoelectronics is a platform-based micro-nano manufacturing firm that creates ornamental films for electrical appliances and portable electronics.
  • Xindi Digital Engineering System — Xindi Digital Engineering System specializes in the development of 3D CAD software for manufacturing enterprises.
Green Pine Capital Partners VC Fund · Shenzhen, Guangdong, China · 3 investments in the past 12 months
Green Pine Capital Partners is a venture capital firm.
Show more
Investment focus
  • Artificial Intelligence, Manufacturing, Software
  • Series A, Angel, Series B
  • China, United States, Canada
Portfolio highlights
  • Baisios — Baisios is a developer of tumor immune cell therapy technology and is dedicated to the growth of the tumor biotherapy industry.
  • Youyun — Youyun is the designer of a full-stack operation and maintenance service platform aimed at increasing company efficiency. They specialize in creating a variety of cloud-based business software solutions that increase the effectiveness of enterprise management and maintenance while enabling quick and efficient digital transportation for a range ofsectors.
  • Jiangxing Intelligence — Jiangxing Intelligence was founded in 2018 by internationally renowned scientists, academician of the Canadian Academy of Engineering, and IEEE Fellow Professor Liu Jiangchuan. The company is committed to the development of advanced edge computing technology and its application in the fields of energy Internet, industrial security, and intelligentwarehousing. At the beginning of the company's establishment, it has obtained tens of millions of venture capital from Sequoia Capital China Seed Fund.
Haibang Capital VC Fund · Hangzhou, Zhejiang, China · 4 investments in the past 12 months
Zhejiang Haibang Investment Management Co., Ltd. (also referred as "Haibang Capital") is an investment company focusing on venture capital and private equity. It was established in 2011 in Hangzhou. It was founded by Naxin Yao, the CEO of Focused Photonics, Inc (300203), a number of returnee entrepreneurs and experienced investmentprofessionals. In 2011, Haibang Capital launched its first Haibang Fund (formerly called “Haibang Talent Fund”) which was the first venture capital in China helping new returnees to start their own businesses. It is also a fund connect capital and "Thousand Talent Program" in Zhejiang Province. Haibang Capital keeps working on helping enterprises grow rapidly and build leading edge in their industry. In addition to providing capitals, Haibang Capital provides its investee companies with personalized value-added services, helping create both good economic and social benefits.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Angel, Series B
  • China
Portfolio highlights
  • MetaLenX — MetaLenX is a technology-based enterprise focusing on the design, manufacture and application of superlenses.
  • Zhiwei Technology — Zhiwei Technology provides microporous foam sheets made of polymer supercritical microcellular foaming that are lightweight and durable.
  • LYNK Pharmaceuticals — LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.
Baidu Ventures VC Fund · Beijing, Beijing, China · 8 investments in the past 12 months
"BV is an independent venture fund established by Baidu in 2017. BV's investors include Baidu as well as other leading financial institutions and businesses. BV currently manages roughly $500M USD across 3 funds and has offices in Beijing and San Francisco. Its mission is to support entrepreneurs and companies who are spearheading the newage of artificial intelligence. These companies are changing the way we work and live—and ultimately how we interact."
Show more
Investment focus
  • Artificial Intelligence, Health Care, Biotechnology
  • Series A, Seed, Series B
  • China, United States, Germany
Portfolio highlights
  • UDEER.AI — UDEER.AI is a robotics company that focuses on embodied intelligence technology and specializes in the development of universal brains for robots.
  • Huayi Quantum — Huayi Quantum is a quantum computer and quantum cloud platform developer specializing in advanced algorithm research and application acceleration.The business creates modular, standardized, and scalable quantum computers based on ion-trap technology.
  • Jiangxing Intelligence — Jiangxing Intelligence was founded in 2018 by internationally renowned scientists, academician of the Canadian Academy of Engineering, and IEEE Fellow Professor Liu Jiangchuan. The company is committed to the development of advanced edge computing technology and its application in the fields of energy Internet, industrial security, and intelligentwarehousing. At the beginning of the company's establishment, it has obtained tens of millions of venture capital from Sequoia Capital China Seed Fund.
Cenova VC Fund · Shanghai, Shanghai, China
Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system. CenovaCapital is healthcare funds dedicated to early and growth-stage investments in the life sciences and healthcare sector in China. Since inception in 2010, Cenova now has five funds under management with investments in over 50 companies in healthcare services, pharmaceuticals, medical devices and digital heath. Cenova's investors are mainly large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series B, Series A, Series C
  • China, Singapore, United States
Portfolio highlights
  • Phage Pharm — Phage Pharm is a professional enterprise in the industrialization of bacteriophages.
  • Jiangsu Jland Biotech — Jiangsu Jland Biotech is dedicated to the development and production of Biollagen™ collagen and is determined to be the biggest non-animal-sourced collagen supplier worldwide.
  • Hunan Yiyi Pharmaceutical Technology — Hunan Yiyi Pharmaceutical Technology
Tiantu Capital VC Fund · Shenzhen, Guangdong, China · 2 investments in the past 12 months
Tiantu Capital is a venture capital association.
Show more
Investment focus
  • Food and Beverage, E-Commerce, Internet
  • Series A, Series B, Series C
  • China, United States, Japan
Portfolio highlights
  • BaiTube — BaiTube is a provider of Multi-Channel Network short video services. Its businesses include short videos, live e-commerce, and brand marketing that help users with different needs and easily find interesting and useful videos online.
  • EVENTEC — EVENTEC is a service robot system solution provider.
  • Leman Biotech — Leman Biotech is a biotech company that is engaged in development of cancer immunotherapies.
Fortune Venture Capital VC Fund · Shenzhen, Guangdong, China · 20 investments in the past 12 months
Fortune Capital, established in April, 2000, is one of the earliest market-oriented venture capital firms in China. For the past 14 years, Fortune Capital focus its investments on leading companies in four key sectors: TMT (Media oriented), Consumer Goods/Services, Modern Agriculture and Clean Tech.Fortune Capital is ranked among thehighest performing VC/PE firms in China and selected as "Vice President of Venture Capital Committee of IAC," "Vice President of Shenzhen VC Association," "Vice President of Shenzhen Chamber of International Investment & Funding," etc.In addition to providing capitals, Fortune Capital provides its investee companies with personalized value-added services.
Show more
Investment focus
  • Manufacturing, Information Technology, Health Care
  • Series A, Series B, Series C
  • China, Japan, United States
Portfolio highlights
  • GZTech — GZTech is a technology company that specializes in the development, production, and sale of advanced industrial lasers and light sources for precision.
  • HYPS energy — HYPS energy is a developer of smart operation and maintenance services for photovoltaic power stations and flexible bracket systems. They offer customized solutions, including investment consulting, EPC construction, power station operation, and energy sales.
  • Pleiades — Pleiades is a one-stop platform to build, optimize, manage, and ship cost-effective AI deployment solutions. Qingyuan Intelligence has launched MLGuider, a reasoning optimization tool chain for AI models, which is adapted and optimized for the current mainstream hardware environment.
Lotus Lake Ventures VC Fund · Beijing, Beijing, China · 3 investments in the past 12 months
Lotus Lake Ventures is an investment firm committed to investing in science and technology innovation enterprises, focusing on high-tech and high-tech enterprises with core competitiveness in the initial stage and growth stage..
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Series C
  • China
Portfolio highlights
  • Kanova — Kanova is a biopharmaceutical firm.
  • Better Medtech — Better Medtech is a provider of innovative solutions for urinary and pelvic floor health. Its primary business is the research and development, production, sales, and related services of specialized medical devices, with a focus on creating comprehensive and precise revolutionary products in markets such as benign prostatic hyperplasia, urinaryincontinence, stones, and novel tumour therapies.
  • Juzheng Medical — Juzheng Medical develops medical device products, specializing in the study, creation, and manufacturing of medical devices. It is committed to providing innovative medical devices for vascular interventional treatments.
Redhill Capital VC Fund · Guangzhou, Guangdong, China · 2 investments in the past 12 months
Redhill Capital is a venture capital firm specializing in early stage investment. It primary invests in medical industry.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Seed, Series A, Angel
  • China
Portfolio highlights
  • Douli — Douli is an employee service platform that provides welfare solutions for enterprises. They offer services in the fields of clothing, food, housing, transportation, medical care, entertainment, and more by combining online and offline multi-channel resources.
  • Inflamax Pharmaceuticals — Inflamax Pharmaceuticals is a biomedical technology company that specializes in the innovation and development of immune-inflammatory drugs.
  • EnCureGen Pharmaceuticals — Huizhengqi Medicine is a pharmaceutical company that develops mRNA drugs for the treatment of tumor and immunity diseases.
Oriza Seed Capital (Oriza Yuandian) VC Fund · Suzhou, Jiangsu, China · 5 investments in the past 12 months
Oriza Seed Venture Capital, located in Suzhou Industrial Park, is held by Suzhou Oriza Holdings Ltd. Oriza Seed is a market-oriented investment platform. It looks for investment opportunities among early-stage and growth-stage enterprises in the fields of Healthcare and TMT. Oriza Seed has ample resources and experiences investing in the healthcarefield. By late March 2016, Oriza Seed has invested in more than 50 healthcare companies, including Ascentage Pharma, Innovent Biologics, and SceneRay Corporation.
Show more
Investment focus
  • Manufacturing, Health Care, Biotechnology
  • Series A, Seed, Angel
  • China, United States
Portfolio highlights
  • Simnova — Simnova Biotherapeutics is a biopharmaceutical company that focuses on the research and development of cell therapies for cancer treatment. The company's primary therapeutic focus is CAR-based cell therapy for patients with either hematologic malignancies or solid tumors. Simnova Biotherapeutics is known for its innovative approach todeveloping patient-centered therapeutics using current science and technology. The company's lead product is SNC102, a cell therapy product that has been approved for clinical trials. Simnova Biotherapeutics is committed to creating a healthy, inclusive, and harmonious working environment.
  • Xinhong life — Xinhong Life is a technologically creative medical company dedicated to developing a medical enterprise based on ultrasound energy technology as well as combining drug and device technology. Xinhong Life, which specializes in interventional ultrasound technology and combined drug-device technology, has developed a number of technology platforms,including interventional ultrasound energy technology, combined drug-device technology, software and algorithm architecture technology, and industrial transformation platforms, and continues to develop innovative energy device products that truly address clinical pain points.
  • Daoyi Semiconductor — Daoyi Semiconductor is a company that specializes in the research and development, manufacturing, sales, and technical support of epoxy plastic encapsulating materials for various semiconductor devices, integrated circuits, power modules, and other electronic packaging.
Lenovo Capital and Incubator Group (LCIG) VC Fund · Beijing, Beijing, China · 31 investments in the past 12 months
Lenovo Capital and Incubator Group is an accelerator and venture capital firm.
Show more
Investment focus
  • Software, Artificial Intelligence, Manufacturing
  • Series A, Series B, Seed
  • China, Hong Kong, United States
Portfolio highlights
  • ONYX BOOX — ONYX BOOX offers a truly paper-like experience for reading and note-taking.
  • Shexu Technology — Established in 2020, Shanghai Shexu Technology Co., Ltd. is an AI-driven industrial design software R&D technology enterprise and design service provider. The company has a professional scientific research and technical team, and has independently developed automatic industrial design software based on AI computing engine. The design softwarehas been widely used in the field of automotive industry equipment, significantly improving the design efficiency of industrial machinery designers.
  • Jiangxing Intelligence — Jiangxing Intelligence was founded in 2018 by internationally renowned scientists, academician of the Canadian Academy of Engineering, and IEEE Fellow Professor Liu Jiangchuan. The company is committed to the development of advanced edge computing technology and its application in the fields of energy Internet, industrial security, and intelligentwarehousing. At the beginning of the company's establishment, it has obtained tens of millions of venture capital from Sequoia Capital China Seed Fund.
Source Code Capital VC Fund · Chaoyang, Liaoning, China · 10 investments in the past 12 months
Founded in 2014, Source Code Capital is a leading China VC focused on the broad TMT sectors and investing in both early stage start-ups and growth stage companies. With $1.5 billion and RMB 3.5 billion under management, Source Code Capital has been successfully partnering with close to 150 leading Chinese technology founders since inceptionincluding Bytedance, Meituan, Homelink, among many others. Source Code is focused on the “Big 3” fundamental drivers, which are Internet+, AI+, and Global+ , and invests along sectors such as media and entertainment, consumer services, enterprise, finance, retail, transportation, housing, education, and healthcare.
Show more
Investment focus
  • Software, E-Commerce, Artificial Intelligence
  • Series B, Series A, Series C
  • China, United States, Singapore
Portfolio highlights
  • Pinch Ta — Pinch Ta focus on developing a content engine that utilizes AI to enhance creativity, address data, effects, copyright, and commercial utilization issues. "Pinch Ta" AI co-creation community, contributing character fine-tuning models for popular IPs like Genshin Impact and creating its own character director. "The Sims" offersAI comics and virtual character content.
  • Galaxy Bot — Galaxy Bot is an innovative robotics company that provides intelligent universal service robotic products.
  • Accelerating Evolution — Accelerating Evolution is a humanoid robotics company. It provides humanoid robots to AI firms and research institutes, as well as quick mass production and supply of standard items.
Sunland Fund VC Fund · Shanghai, Shanghai, China · 7 investments in the past 12 months
Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp..
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Series A, Series B, Seed
  • China
Portfolio highlights
  • JH Cispoly — JH Cispoly develops diagnostic technology and equipment for gynecological tumors.
  • Better Medtech — Better Medtech is a provider of innovative solutions for urinary and pelvic floor health. Its primary business is the research and development, production, sales, and related services of specialized medical devices, with a focus on creating comprehensive and precise revolutionary products in markets such as benign prostatic hyperplasia, urinaryincontinence, stones, and novel tumour therapies.
  • Juhe Biotechnology — Juhe Biotechnology is a company that creates early detection tools for gynecological malignancies.
Investors by industry
Investors by country
VC Funds in China by industry